About this episode

The episode discusses the potential economic impacts of weight-loss drugs and falling obesity rates.

Will weight-loss drugs fuel the global economy, or give it indigestion? Host Carmel Crimmins talks to Michele Gershberg, global health editor and U.S. business editor David Gaffen about the impact of falling obesity rates on consumer spending, productivity and government finances. Sign up for the ⁠⁠Reuters Econ World ⁠⁠⁠newsletter⁠⁠⁠⁠ Produced by Eliza Davis Beard Sound engineering and music by Josh Sommer Visit the ⁠Thomson Reuters Privacy Statement⁠ for information on our privacy and data protection practices. You may also visit ⁠megaphone.fm/adchoices⁠ to opt out of targeted advertising. Our Standards: ⁠**The Thomson Reuters Trust Principles.⁠** Further listening Dating apps Is Big Tech too big to slow down? Labor market limbo ⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

More episodes of Reuters Econ World

• Kevin Warsh’s policy trap · April 22, 2026 · 34 min
• The economics of $60-plus cigarettes · April 15, 2026 · 34 min
• Safe havens · April 8, 2026 · 41 min
• Live podcast: The affordability gap · April 1, 2026 · 47 min
• Will Trump’s Iran war jumpstart the EV revolution? · March 25, 2026 · 37 min
• Adam Smith’s time to shine · March 18, 2026 · 27 min

Explore listener stats, chart rankings, contacts and more on the Reuters Econ World podcast page.